Search research articles
Contact Us
Filters
Showing results (61-70 of 69) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 69 results.
International Journal of Cancer
|
August 10, 2019
CD4 T cells target colorectal cancer antigens upregulated by oxaliplatin
Jeanne Galaine, Célia Turco, Charline Vauchy, et al.
Molecular Therapy. Oncology
|
January 1, 2026
Evaluation of dasatinib and ponatinib for the control of CD123 CAR-T cell functionalities
Charles-Frédéric Mantion, Sabeha Biichlé, Xavier Roussel, et al.
Anti-Cancer Drugs
|
November 1, 2006
Feasibility of using intraperitoneal epinephrine and cisplatin in patients with advanced peritoneal carcinomatosis
Cécile Molucon-Chabrot, Nicolas Isambert, Laurent Benoit, et al.
Annals of Surgical Oncology
|
January 7, 2022
Cytoreductive Surgery and Intraperitoneal Chemotherapy in Advanced Serous Epithelial Ovarian Cancer: A 14-Year French Retrospective Single-Center Study of 124 Patients
Brice Paquette, Elsa Kalbacher, Frédéric Mercier, et al.
Mabs
|
March 30, 2017
A new anti-mesothelin antibody targets selectively the membrane-associated form
Kamal Asgarov, Jeremy Balland, Charline Tirole, et al.
British Journal of Clinical Pharmacology
|
September 15, 2022
Quantitative impact of pre-analytical process on plasma uracil when testing for dihydropyrimidine dehydrogenase deficiency
Maud Maillard, Manon Launay, Bernard Royer, et al.
Haematologica
|
November 9, 2014
In vivo and in vitro sensitivity of blastic plasmacytoid dendritic cell neoplasm to SL-401, an interleukin-3 receptor targeted biologic agent
Fanny Angelot-Delettre, Anne Roggy, Arthur E Frankel, et al.
Bulletin Du Cancer
|
March 1, 2018
[Dihydropyrimidine déhydrogenase (DPD) deficiency screening and securing of fluoropyrimidine-based chemotherapies: Update and recommendations of the French GPCO-Unicancer and RNPGx networks]
Marie-Anne Loriot, Joseph Ciccolini, Fabienne Thomas, et al.
Cancer Research
|
May 20, 2016
Rapalogs Efficacy Relies on the Modulation of Antitumor T-cell Immunity
Laurent Beziaud, Laura Mansi, Patrice Ravel, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 69) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 69 results.
International Journal of Cancer
|
August 10, 2019
CD4 T cells target colorectal cancer antigens upregulated by oxaliplatin
Jeanne Galaine, Célia Turco, Charline Vauchy, et al.
Molecular Therapy. Oncology
|
January 1, 2026
Evaluation of dasatinib and ponatinib for the control of CD123 CAR-T cell functionalities
Charles-Frédéric Mantion, Sabeha Biichlé, Xavier Roussel, et al.
Anti-Cancer Drugs
|
November 1, 2006
Feasibility of using intraperitoneal epinephrine and cisplatin in patients with advanced peritoneal carcinomatosis
Cécile Molucon-Chabrot, Nicolas Isambert, Laurent Benoit, et al.
Annals of Surgical Oncology
|
January 7, 2022
Cytoreductive Surgery and Intraperitoneal Chemotherapy in Advanced Serous Epithelial Ovarian Cancer: A 14-Year French Retrospective Single-Center Study of 124 Patients
Brice Paquette, Elsa Kalbacher, Frédéric Mercier, et al.
Mabs
|
March 30, 2017
A new anti-mesothelin antibody targets selectively the membrane-associated form
Kamal Asgarov, Jeremy Balland, Charline Tirole, et al.
British Journal of Clinical Pharmacology
|
September 15, 2022
Quantitative impact of pre-analytical process on plasma uracil when testing for dihydropyrimidine dehydrogenase deficiency
Maud Maillard, Manon Launay, Bernard Royer, et al.
Haematologica
|
November 9, 2014
In vivo and in vitro sensitivity of blastic plasmacytoid dendritic cell neoplasm to SL-401, an interleukin-3 receptor targeted biologic agent
Fanny Angelot-Delettre, Anne Roggy, Arthur E Frankel, et al.
Bulletin Du Cancer
|
March 1, 2018
[Dihydropyrimidine déhydrogenase (DPD) deficiency screening and securing of fluoropyrimidine-based chemotherapies: Update and recommendations of the French GPCO-Unicancer and RNPGx networks]
Marie-Anne Loriot, Joseph Ciccolini, Fabienne Thomas, et al.
Cancer Research
|
May 20, 2016
Rapalogs Efficacy Relies on the Modulation of Antitumor T-cell Immunity
Laurent Beziaud, Laura Mansi, Patrice Ravel, et al.
Page
of 7